SETTLEMENT AGREEMENTSettlement Agreement • February 28th, 2022 • Theravance Biopharma, Inc. • Pharmaceutical preparations
Contract Type FiledFebruary 28th, 2022 Company IndustryTHERAVANCE BIOPHARMA IRELAND LIMITED whose registered office is at Connaught House, 1 Burlington Road, Dublin 4, D04 C5Y6 (the “Company”, which expression shall, where the context so permits or requires, include any Group Company (as defined below); and
CONSULTING AGREEMENTConsulting Agreement • February 28th, 2022 • Theravance Biopharma, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 28th, 2022 Company Industry JurisdictionEffective November 30, 2021 (the “Effective Date”), Vijay Sabesan (“Consultant”) and Theravance Biopharma US, Inc. (“Theravance Biopharma” or the “Company”) agree as follows:
SEPARATION AGREEMENT AND RELEASE OF CLAIMSSeparation Agreement and Release of Claims • February 28th, 2022 • Theravance Biopharma, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 28th, 2022 Company Industry JurisdictionThis Separation Agreement and Release of Claims (“Agreement”) is made and entered into by and between [________] (“Employee”) and Theravance Biopharma US, Inc. (“Theravance” or “Company”). Employee and Theravance shall be referred to herein as the “Parties.”